Brooklyn ImmunoTherapeutics (NYSE:BTX) Trading Up 5.1%

Shares of Brooklyn ImmunoTherapeutics Inc (NYSE:BTXGet Rating) were up 5.1% during trading on Wednesday . The stock traded as high as $3.44 and last traded at $3.28. Approximately 8,480 shares changed hands during mid-day trading, The stock had previously closed at $3.12.

Wall Street Analyst Weigh In

Separately, StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics in a report on Thursday, November 17th. They issued a “hold” rating on the stock.

Brooklyn ImmunoTherapeutics Stock Up 0.0 %

Institutional Inflows and Outflows

An institutional investor recently raised its position in Brooklyn ImmunoTherapeutics stock. Renaissance Technologies LLC increased its stake in Brooklyn ImmunoTherapeutics Inc (NYSE:BTXGet Rating) by 20.1% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,459,626 shares of the company’s stock after acquiring an additional 243,826 shares during the quarter. Renaissance Technologies LLC owned 2.48% of Brooklyn ImmunoTherapeutics worth $360,000 at the end of the most recent reporting period.

Brooklyn ImmunoTherapeutics Company Profile

(Get Rating)

Eterna Therapeutics, Inc is a clinical stage biopharmaceutical company, which engages in creating transformative regenerative medicine treatments for cancer, blood disorders, and monogenic diseases. It offers IRX-2, a human cell-derived cytokine therapy, studying the safety and efficacy of IRX-2 in patients with head and neck cancer in Phase 2B.

Featured Stories

Receive News & Ratings for Brooklyn ImmunoTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brooklyn ImmunoTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.